| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1335 | 2020 |
| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1334 | 2020 |
| Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography JE Voss, MC Vaney, S Duquerroy, C Vonrhein, C Girard-Blanc, E Crublet, ... Nature 468 (7324), 709-712, 2010 | 682 | 2010 |
| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 541 | 2020 |
| Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein I Gutsche, F Coulibaly, JE Voss, J Salmon, J d'Alayer, M Ermonval, ... Proceedings of the National Academy of Sciences 108 (19), 8003-8008, 2011 | 334 | 2011 |
| Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody CG Rappazzo, LV Tse, CI Kaku, D Wrapp, M Sakharkar, D Huang, ... Science 371 (6531), 823-829, 2021 | 283 | 2021 |
| Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection G Song, W He, S Callaghan, F Anzanello, D Huang, J Ricketts, JL Torres, ... Nature communications 12 (1), 2938, 2021 | 271 | 2021 |
| Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies LE McCoy, MJ van Gils, G Ozorowski, T Messmer, B Briney, JE Voss, ... Cell reports 16 (9), 2327-2338, 2016 | 231 | 2016 |
| Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design R Andrabi, JE Voss, CH Liang, B Briney, LE McCoy, CY Wu, CH Wong, ... Immunity 43 (5), 959-973, 2015 | 195 | 2015 |
| Reprogramming the antigen specificity of B cells using genome-editing technologies JE Voss, A Gonzalez-Martin, R Andrabi, RP Fuller, B Murrell, LE McCoy, ... Elife 8, e42995, 2019 | 78 | 2019 |
| Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells D Huang, JT Tran, A Olson, T Vollbrecht, M Tenuta, MV Guryleva, ... Nature communications 11 (1), 5850, 2020 | 71 | 2020 |
| Elicitation of neutralizing antibodies targeting the V2 apex of the HIV envelope trimer in a wild-type animal model JE Voss, R Andrabi, LE McCoy, N de Val, RP Fuller, T Messmer, CY Su, ... Cell reports 21 (1), 222-235, 2017 | 68 | 2017 |
| Commercial serology assays predict neutralization activity against SARS-CoV-2 RT Suhandynata, MA Hoffman, D Huang, JT Tran, MJ Kelner, SL Reed, ... Clinical chemistry 67 (2), 404-414, 2021 | 66 | 2021 |
| Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry Q Li, M Zeng, L Duan, JE Voss, AJ Smith, S Pambuccian, L Shang, ... The Journal of Immunology 193 (6), 3113-3125, 2014 | 66 | 2014 |
| Glycans function as anchors for antibodies and help drive HIV broadly neutralizing antibody development R Andrabi, CY Su, CH Liang, SS Shivatare, B Briney, JE Voss, SK Nawazi, ... Immunity 47 (3), 524-537. e3, 2017 | 61 | 2017 |
| B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models D Huang, RK Abbott, C Havenar-Daughton, PD Skog, R Al-Kolla, ... Proceedings of the National Academy of Sciences 117 (37), 22920-22931, 2020 | 47 | 2020 |
| In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice AD Nahmad, CR Lazzarotto, N Zelikson, T Kustin, M Tenuta, D Huang, ... Nature biotechnology 40 (8), 1241-1249, 2022 | 32 | 2022 |
| Autologous antibody responses to an HIV envelope glycan hole are not easily broadened in rabbits YR Yang, LE McCoy, MJ van Gils, R Andrabi, HL Turner, M Yuan, ... Journal of virology 94 (7), 10.1128/jvi. 01861-19, 2020 | 31 | 2020 |
| What do chaotrope-based avidity assays for antibodies to HIV-1 envelope glycoproteins measure? MR Alexander, R Ringe, RW Sanders, JE Voss, JP Moore, PJ Klasse Journal of virology 89 (11), 5981-5995, 2015 | 27 | 2015 |
| Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein AZ Wec, D Wrapp, AS Herbert, D Maurer, D Haslwanter, M Sakharkar, ... BioRxiv, 2020 | 26 | 2020 |
David NemazeeThe Scripps Research InstituteVerified email at scripps.edu
